medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2013, Number 1

<< Back Next >>

Acta Med Cent 2013; 7 (1)

Clinical and epidemiological characterization of patients discharged with heart failure

Ojeda BJC, Pérez BE, Cairo SG, Vega AN, Ruíz MM

Language: Spanish
References: 20
Page:
PDF size: 92.19 Kb.


ABSTRACT

A total of 112 patients diagnosed with chronic heart failure, according to the modified Framingham criteria, who were discharged from the Arnaldo Milian Castro Provincial University Hospital in Santa Clara, Villa Clara, in the period January to December 2010, were studied. The objective was to characterize, clinically and epidemiologically, the inpatient behavior of this syndrome. Females were predominant (57.14%). The leading cause of heart failure was ischemic heart disease. The leading cause of respiratory decompensation was sepsis. The number of diseased patients was higher among patients with two or more comorbidities, those with systolic dysfunction and those inadequately treated before being admitted, and the most frequent causes of death were pneumonia and pulmonary thromboembolism. It was concluded that it could not be demonstrated an association between the studied factors and mortality, and that treatment before admission is still inadequate.


REFERENCES

  1. Lee DS. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009 Jun 23;119(24):3070- 7.

  2. Mann DL. Insuficiencia cardíaca y cor pulmonale. In: Fauci Anthony S, Braunwald E, Kasper DL, Hauser SL, Longo DL, Larry Jamenson J,et al. Principles of Internal Medicine. Vol II. 17th ed. New York: Mc Graw Hill Medical; 2009. p. 1443-55.

  3. Cairo Saéz G, Cervera Cruz CR, Vidal González D, Aparicio F. Variables clínicas asociadas a la mortalidad hospitalaria por Insuficiencia Cardiaca. Card Cong Ann Cir Card Vas. 1996;2(4):139-45.

  4. García MJ. Diagnóstico y guía terapéutica de la insuficiencia cardíaca diastólica. Rev Esp Cardiol [Internet]. 2003 [citado 12 Ago 2009];56(4):[aprox. 19 p.]. Disponible en: http://www.doyma.es/cardio/ctl_servlet?_f=40&ident=13045656.

  5. Guardiola Brizuela RE, Conde Fernández B, Novoa López A, Ornia Margolles MM, González Ibarzabal J. Síndrome de insuficiencia cardíaca. Algunos aspectos novedosos en la clasificación, diagnóstico y tratamiento. Gac Méd Espirit [Internet]. 2006 [citado 12 Ago 2009];8(2):[aprox. 9 p.]. Disponible en: http://bvs.sld.cu/revistas/gme/pub/vol.8.%282%29_10/p10.html

  6. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2007;115:e69-171.

  7. Weil J. Rational diagnostics and current treatment concepts in the management of chronic heart failure. Med Klin (Munich). 2008 Sep 15;103(9):646-62.

  8. Cairo Sáez G, Sánchez Lorenzo AA. Evaluación de la propiedad y el costo de la hospitalización por insuficiencia cardiaca. An Cir Card Vasc. 2004;10(5):284-92.

  9. Cairo Sáez G, Ojeda Blanco JC, Gutiérrez Díaz MJ. Incidencia, prevalencia y manejo de la insuficiencia cardiaca en un grupo básico de trabajo. Villa Clara: Primer encuentro teórico Universalización y Sociedad; 2005.

  10. Jessup M. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. Circ Heart Fail. 2011 May;4(3):378-87.

  11. Negrín Expósito JE, Fernández-Brito Rodríguez JE, Castillo Herrera JA, Senra Armas G, Gutiérrez Rojas A, Pérez Yn M, et al. Prevalencia y formas de insuficiencia cardíaca en mayores de 65 años. Rev Cubana Invest Biomed [Internet]. 2007 [citado 12 Ago 2009];26(2): [aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 03002007000200002&lng=es&nrm=iso&tlng=es

  12. Díez Martínez J. Enfoque traslacional de la insuficiencia cardiaca: del gen al paciente y a la población. Rev Esp Cardiol [Internet]. 2007 [citado 12 Ago 2009];7(Supl F): [aprox. 2 p.]. Disponible en: http://www.doyma.es/cardio/ctl_servlet?_f=40&ident=13110826

  13. Conthe P, Tejerina F. Adhesión al tratamiento y calidad de vida en los pacientes con insuficiencia cardiaca. Rev Esp Cardiol [Internet]. 2007 [citado 12 Ago 2009];7(Supl F): [aprox. 2 p.]. Disponible en: http://www.doyma.es/cardio/ctl_servlet?_f=45&ident=13110832

  14. Venskutonyte L, Molyte I, Ablonskyte-Dūdoniene R, Mizariene V, Kavoliūniene A. Characteristics and management of acute heart failure patients in a single university hospital center. Medicina (Kaunas). 2009;45(11):855-70.

  15. Tang WHW. Glycemic control and treatment patterns in patients with heart failure. Curr Cardiol Rep. 2007;9:242-47.

  16. Roca Goderich R, Smith Smith VV, Paz Presilla E, Lozada Gómez J, Serret Rodríguez B, Llanos Sierra N, et al. Insuficiencia Cardiaca. En: Temas de Medicina Interna. Vol II. La Habana: Ciencias Médicas; 2002. p. 556-67.

  17. Cairo Sáez G, Jiménez Prieto Y, González Rodríguez DS. Predicción de la mortalidad por insuficiencia cardiaca. An Cir Card Cir Vas. 2000; 6(4):173 –79.

  18. Muñoz Aguilera R, Comin Coletb J, Cuenca Castilloc JJ, Delgado Jiménez JF. Insuficiencia cardiaca. Rev Esp Cardiol [Internet]. 2008 [citado 12 Ago 2009];61(12):[aprox. 9 p.]. Disponible en: http://www.revespcardiol.org/watermark/ctl_servlet?_f=10&pident_articulo=131146 42&pident_usuario=0&pident_revista=25&fichero=25v61nSupl.1a13114642pdf001.p df&ty=139&accion=L&origen=cardio&web=www.revespcardiol.org&lan=es

  19. Rector TS. Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (IPRESERVE) trial. Circ Heart Fail. 2012 Mar 1;5(2):217-25.

  20. Piazza G, Goldhaber SZ, Lessard DM, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. Am J Med. 2011 Mar;124(3):252-9.




2020     |     www.medigraphic.com